Dear Zohydro-ban activists, I see twitter is abuzz with all of the frustrated doctors and pharmacists about the hydrocodone becoming schedule 2 drug. I also found one character by the name of Lewis Nelson MD who sided with Shumer on Zohydro ban, now it is interesting he has had a change of heart and tweeted an article that says rescheduling to class 2 is not likely going to stop abusers and shady pharmacies! I challenge you zohydro-ban activists, I know you mean well, after Oct 6, just count how many politicians will switch sides, in order to return hydrocodone to schedule 3. You will soon find out which doctors and politicians that were once outspoken activists against zohydro ER and the addiction epidemic are and have been in the pockets of big pharma all along. Go ahead start with the north eastern states, in particular keep an eye on the New England states, which are big pharma back yards. This rescheduling is a major blow to big pharma, and pharmacy chains, which have been profiting from the sale of tons of hydrocodone in everything from pain meds to cold and cough meds.
Zohydro is not selling all that well, the rate of growth of the prescriptions signals of a limited market size. Lets say you ban this and you get 200 prescriptions out of tens of thousands of Hydrocodone prescriptions off the market every day, 99.9% of which by the way have no ADT. At the end what did you accomplish? There is a small market for Zohydro and frankly those are the patients that need it real badly because they have bad livers and have no other options. All you will be doing is taking it away from the people that will end up dead with bad livers who would need liver transplants if the take APAP. Zohydro is already as good as banned so don't waist your effort. If you want to ban something look at purdue's portfolio, PFE's portfolio and Mylan's porfolio, Teva etc. etc. etc. They are the ones who are making the real bucks in pumping out tons of Hycrocodone every day. So march on in Washington and scream real loud, we are all behind you and want to reduce the number of addicts, but keep in mind you really are going about it the wrong way.
This makes alot of sense, to be honest with you I have no idea why they are even considering dilution when the drug is completely un encumbered both in the u.s. and in e.u and has a run rate of 300m in u.s. and has the potential of doing another 300 in eu.
In all of these 5 states MJ is approved medically and Vermont even decriminalized it up to an ounce. MJ is a schedule I and a gateway drug and no ADT and kids abuse it the most. What a joke!
~21000 up to end of August as of end of July they had ~ 15k prescriptions this makes August a ~6k script month. They said July was ~4k script month in the previous call so this is a nice month over month growth as well.
Sentiment: Strong Buy
They would scream if someone says a bad thing about the morning after pill. A couple years ago a very beautiful girl made the headlines who died of bleeding here in California with that drug, just because she was too embarrassed to take her baby to full term. I am sure her baby would have been as beautiful. What a shame. She made the headlines because of her extraordinary beauty, you wonder how many young girls die of that drug that don't make the headlines.
According to the article Zogenix sales team is inept: In July 2014, Zohydro ER’s sixth month of marketing, there were 3588 outpatient retail prescriptions dispensed. This represents 0.23% of the 1.6 million ER/LA opioid analgesic prescriptions and 0.02% of the nearly 18 million prescriptions dispensed for all opioid analgesics during the month.
I would think the pain and suffering caused by going to emergency room because you over dosed on APAP while you were on pain meds justify's a lawsuit...
This guy is operating under this fake name (Scruffy Fitch) for about 5 months and all of his comments in all news sources is against zohydro and Zogenix. He pretends to have been a pain patient on morphine who somehow cured himself and his mission in life is to make Zohydro a schedule 1 drug. He even makes disparaging remarks about Zo management, and their salaries and Z cash position, which is even more surprising because he claims to gave no financial interest in his mission. He claims to have started companies and sold them one of which is supposedly a fortune something company. For someone so successful he has time for long verbose diatribes and all against Z. Can anyone expose this guy?
The first night I remember sitting in my chair holding my arm in steady position looking at the clock to see when it is time for my next dose per my doctor's prescription. I had already taken triple the dosage of oxicodone, when the pain started, and in the conversation with my the doctor he warned me of liver damage if I take more than what the prescription says. There was no sleeping in the cards for me the first night at all and I welcomed daylight just because I had passed the night. The sever pain lasted for 2 weeks and the doctor sent me to rehab on the third day and had me move my arm even though every movement caused excruciating pain. Beyond that the sever pain persisted for 3 months, and moderate pain after that for the first year. When they fix your shoulder the pull the tenants and tighten them so the shoulder socket is really tight and there is not enough lubricant in the joint to facilitation motion so every motion is painful. The range of motion is also limited so as you extend beyond the range of motion, whether accidentally or on purpose you experience excruciating pain. In my opinion, every doctor who does shoulder surgery should have the 20mg Zohydro option available for their patients.
On a weekly basis and q over q, fIrst 4 weeks of July ~4k the remaining 5 weeks to the end of August ~6k, 4.5 weeks to the end of the quarter and we are already roughly over the last quarter's number. Mind you we are doing a very measured and responsible marketing campaign.
This quarter they will likely lose 25 million and their cash will likely be down roughly the same amount down to 56M
The fact that the drug does not sell has no thing to do with the CEO, he already has 190 people in the commercial organization and the drug has already gotten so much publicity that every patient and doctor already knows about it. As far as I am concern even if gets rid of all of his sales staff, the drug will continue to sell at the current pace just because of the awareness caused by the media.. The fact is the drug itself has a limited market potential. Perhaps because there are not too many patients with bad livers at least not yet. Assuming they got 1225 perscrptions (as reported by someone on this board) on the second week of September it is not too hard to surmise that the scripts will grow over time and probably plateu around 3k prescriptions per week some times next year so they just have to adjust the cost structure to that run rate and focus on the other drug.